Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06354777 · ClinicalTrials.gov registry record
REView of ProcEdural FactoRs and Outcomes After Atrial Fibrillation Ablation With Active Esophageal COOLing: A Sub-Study of the REAL AF Registry
A clinical trial of Atrial Fibrillation, sponsored by Heart Rhythm Clinical and Research Solutions.
- Active
- Registry status
- 312
- Enrollment target
- 6
- Study locations
NCT06354777 is a study of Atrial Fibrillation that is active but no longer recruiting, run by Heart Rhythm Clinical and Research Solutions. The registered enrollment target is 312 participants, below the 2,995-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (90% lower). The trial reports 6 study locations across 6 states.
The verdict
NCT06354777, a study of Atrial Fibrillation, is active but no longer recruiting, sponsored by Heart Rhythm Clinical and Research Solutions.
- ACTIVE NOT RECRUITING
- Registry status
- 312 participants
- Enrollment target
- 6
- Study locations
Study Summary
This is a multi-center sub-study examining the effectiveness of active esophageal cooling on subjects undergoing left atrial ablation for symptomatic Paroxysmal Atrial Fibrillation or Persistent Atrial Fibrillation.
Conditions Studied
Interventions
- DEVICE Atrial Ablation
Study Locations (6)
Arizona
- Valley Heart Rhythm Specialists - Chandler
Indiana
- Ascension St. Vincent Hospital Indianapolis - Indianapolis
Michigan
- Corewell Health Research Institute - Royal Oak
Ohio
- Christ Hospital - Cincinnati
Pennsylvania
- Allegheny General Hospital - Pittsburgh
Washington
- MultiCare Institute for Research & Innovation - Tacoma
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 312 participants |
| Start Date | 2024-04-03 |
| Est. Completion | 2026-12-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06354777
The ClinicalTrials.gov registry entry for NCT06354777 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 312 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,995-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (90% lower). The listed sponsor is Heart Rhythm Clinical and Research Solutions, which has 9 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Atrial Fibrillation appearing as the primary indexed condition, and to 1 intervention - of which Atrial Ablation is the first listed.
NCT06354777 reports 6 study locations spanning 6 distinct geographic areas - top geographies include Arizona, Indiana, Michigan.
Frequently Asked Questions
What is clinical trial NCT06354777 about?
NCT06354777 is a clinical study titled "REView of ProcEdural FactoRs and Outcomes After Atrial Fibrillation Ablation With Active Esophageal COOLing: A Sub-Study of the REAL AF Registry". This is a multi-center sub-study examining the effectiveness of active esophageal cooling on subjects undergoing left atrial ablation for symptomatic Paroxysmal Atrial Fibrillation or Persistent Atrial Fibrillation.
What is the current status of trial NCT06354777?
This trial is currently active not recruiting. The enrollment target is 312 participants. The study started on 2024-04-03. Estimated completion is 2026-12-30.
What conditions does trial NCT06354777 study?
This clinical trial studies the following conditions: Atrial Fibrillation.
What interventions are being tested in trial NCT06354777?
The interventions under investigation include: Atrial Ablation (DEVICE).
Who is sponsoring clinical trial NCT06354777?
This trial is sponsored by Heart Rhythm Clinical and Research Solutions, which has 9 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06354777 being conducted?
This trial has 6 study locations across Arizona, Indiana, Michigan, Ohio, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Atrial Fibrillation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
TIRzepatide for the Treatment of Obesity in Patients With Atrial Fibrillation
RECRUITING · Phase 2
-
Amiodarone for the Prevention of Atrial Fibrillation After Minimally Invasive Esophagectomy in Patients With Esophageal Cancer
RECRUITING · Phase 2
-
The Dynamics of Human Atrial Fibrillation
RECRUITING
-
Renal Denervation + PVI vs PVI Alone for Persistent AF
RECRUITING · NA
-
Pericardiotomy in Cardiac Surgery
RECRUITING · NA
-
CellFX® Nanosecond Pulsed Field Ablation (nsPFA)™ Cardiac Surgery Clamp System to Treat Atrial Fibrillation
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.